PATENT ASSIGNEE'S COUNTRY | USA |
UPDATE | 03.00 |
PATENT ASSIGNEE | This data is not available for free |
PATENT CLAIMS |
Method of screening a drug for deleterious side effects on cell comprising - Assaying for the amount of expression in the cell of > 2 ge nes selected from: G6PD, Ca channel, Synaptogamin, Neuromodulin, Calmodulin, Nicotinic acetylcholine recep tor beta 2, VLDLR, Udulin1/Undulin/Extracellular matrix glycoprotein, Pyruvate dehydrogenase E1, Apolipoprotein B100, Hepatocyte gf, IGF binding protein 1, Ubiquitin, Bone morphogenetic protein precursor, Cytochrome p450-2E1, & Thymosin beta-10 Wherein expression in the cell is assayed before & after the cell has been contacted with the drug Wherein alteration of the amount of expression of at least one of these genes by the drug is indicative of deleterious side effect |
PATENT PHOTOCOPY | Available on request |
Want more information ? Interested in the hidden information ? Click here and do your request. |